Total Payments
$95,646
2024 Payments
$11,777
Companies
14
Transactions
97
Medicare Patients
96
Medicare Billing
$17,026
Payment Breakdown by Category
Consulting$71,962 (75.2%)
Research$16,362 (17.1%)
Travel$6,093 (6.4%)
Food & Beverage$1,229 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $71,962 | 42 | 75.2% |
| Unspecified | $16,362 | 6 | 17.1% |
| Travel and Lodging | $6,093 | 15 | 6.4% |
| Food and Beverage | $1,229 | 34 | 1.3% |
Payments by Type
General
$79,284
91 transactions
Research
$16,362
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $29,088 | 21 | $0 (2024) |
| Janssen Research & Development, LLC | $20,091 | 32 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $12,362 | 3 | $0 (2017) |
| AbbVie Inc. | $9,967 | 11 | $0 (2023) |
| Alfasigma USA, Inc. | $7,565 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $6,713 | 8 | $0 (2020) |
| Boehringer Ingelheim International GmbH | $4,200 | 3 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $3,000 | 3 | $0 (2024) |
| Takeda Development Center Americas, Inc. | $2,429 | 8 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $87.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,777 | 16 | Janssen Scientific Affairs, LLC ($8,348) |
| 2023 | $20,051 | 21 | AbbVie Inc. ($9,967) |
| 2022 | $12,170 | 6 | Janssen Scientific Affairs, LLC ($7,130) |
| 2021 | $10,665 | 4 | Alfasigma USA, Inc. ($7,565) |
| 2020 | $4,500 | 2 | Janssen Pharmaceuticals, Inc ($3,100) |
| 2019 | $17,369 | 23 | Janssen Research & Development, LLC ($12,756) |
| 2018 | $3,106 | 5 | Janssen Scientific Affairs, LLC ($3,000) |
| 2017 | $16,007 | 20 | ACADIA Pharmaceuticals Inc ($12,362) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $54.61 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/19/2024 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $2,025.00 | General |
| Category: Neuroscience | ||||||
| 07/12/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 06/11/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 06/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $35.15 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/31/2024 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $4,725.00 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | In-kind items and services | $706.69 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | In-kind items and services | $312.17 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $55.61 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $28.05 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $9.76 | General |
| 05/02/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $9.76 | General |
| 04/30/2024 | Janssen Scientific Affairs, LLC | — | Travel and Lodging | In-kind items and services | $275.68 | General |
| 04/23/2024 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: Neuroscience | ||||||
| 02/14/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REJOYN (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/10/2024 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 12/20/2023 | Janssen Scientific Affairs, LLC | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $620.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2023 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $5,960.83 | General |
| 12/11/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 10/22/2023 | AbbVie Inc. | — | Travel and Lodging | In-kind items and services | $90.96 | General |
| 10/22/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $34.33 | General |
| 10/22/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 10/21/2023 | AbbVie Inc. | — | Travel and Lodging | In-kind items and services | $153.64 | General |
| 10/20/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 10/20/2023 | AbbVie Inc. | — | Travel and Lodging | In-kind items and services | $702.80 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-042 | ACADIA Pharmaceuticals Inc | $12,362 | 3 |
| Decision aid to enable people with treatment resistant depression and physicians to weigh available evidence along with individuals preferences and values relative to the decision of using a ketamine agent versus alternatives | Janssen Scientific Affairs, LLC | $4,000 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 14 | $3,444 | $931.30 |
| 2022 | 2 | 26 | 43 | $12,947 | $3,830 |
| 2021 | 2 | 41 | 80 | $22,976 | $9,089 |
| 2020 | 1 | 17 | 44 | $10,824 | $3,176 |
Total Patients
96
Total Services
181
Medicare Billing
$17,026
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 14 | $3,444 | $931.30 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 23 | $8,027 | $2,470 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 20 | $4,920 | $1,360 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 48 | $11,808 | $4,571 | 38.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 32 | $11,168 | $4,518 | 40.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 44 | $10,824 | $3,176 | 29.3% |
About Richard Shelton
Richard Shelton is a Psychiatry healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285726612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Shelton has received a total of $95,646 in payments from pharmaceutical and medical device companies, with $11,777 received in 2024. These payments were reported across 97 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($71,962).
As a Medicare-enrolled provider, Shelton has provided services to 96 Medicare beneficiaries, totaling 181 services with total Medicare billing of $17,026. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Birmingham, AL
- Active Since 09/30/2006
- Last Updated 10/25/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1285726612
Products in Payments
- SPRAVATO (Drug) $25,678
- NUPLAZID (Drug) $12,362
- Trintellix (Drug) $2,516
- VRAYLAR (Drug) $2,300
- REJOYN (Device) $1,000
- Auvelity (Drug) $54.61
- Qelbree (Drug) $35.15
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $22.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Birmingham
Armand Schachter, Md, MD
Psychiatry — Payments: $829,953
Psychiatry $829,953
Stephen Hughes, Md, MD
Psychiatry — Payments: $729,216
Psychiatry $729,216
Godehard Oepen, Md, MD
Psychiatry — Payments: $700,544
Psychiatry $700,544
Dr. Leesha Ellis-Cox, Md, Mph, MD, MPH
Psychiatry — Payments: $519,407
Psychiatry $519,407
Matthew Macaluso
Psychiatry — Payments: $66,173
Psychiatry $66,173
Dr. Santosh Pillai, D.o, D.O
Psychiatry — Payments: $30,952
Psychiatry $30,952